Aurora Cannabis Announces 2025 AGM Results and Board Changes

Aurora Cannabis ( (TSE:ACB) ) has issued an announcement.

Aurora Cannabis Inc. announced the results of its 2025 Annual General and Special Meeting, where shareholders voted on various resolutions, including the election of directors and the appointment of auditors. Theresa Firestone resigned from the Board of Directors, and Michael Singer was appointed as the new Lead Independent Director and Chair of the Human Resources and Compensation Committee. The meeting also saw the approval of amendments to the company’s RSU Plan, PSU Plan, and Share Option Plan, although the advisory vote on executive compensation did not pass.

The most recent analyst rating on (TSE:ACB) stock is a Buy with a C$9.00 price target. To see the full list of analyst forecasts on Aurora Cannabis stock, see the TSE:ACB Stock Forecast page.

Spark’s Take on TSE:ACB Stock

According to Spark, TipRanks’ AI Analyst, TSE:ACB is a Neutral.

Aurora Cannabis’s overall stock score reflects a mix of improving financial performance and strategic achievements in the global medical cannabis market. However, ongoing valuation challenges, bearish technical indicators, and cash flow issues weigh on the score.

To see Spark’s full report on TSE:ACB stock, click here.

More about Aurora Cannabis

Aurora Cannabis Inc. is a leading global medical cannabis company based in Canada, serving both medical and consumer markets across Canada, Europe, Australia, and New Zealand. The company is known for its high-quality cannabis products and brands such as Drift, San Rafael ’71, and MedReleaf, among others. Aurora is dedicated to innovation and improving lives through cannabis, and it holds a controlling interest in Bevo Farms Ltd., a major supplier of propagated agricultural plants.

Average Trading Volume: 492,307

Technical Sentiment Signal: Strong Sell

Current Market Cap: C$326.8M

Learn more about ACB stock on TipRanks’ Stock Analysis page.